Literature DB >> 10722705

CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis.

C Grullich1, M C Sullards, Z Fuks, A H Merrill, R Kolesnick.   

Abstract

Although numerous studies document caspase-independent ceramide generation preceding apoptosis upon environmental stress, the molecular ordering of ceramide generation during cytokine-induced apoptosis remains uncertain. Here, we show that CD95-induced ceramide elevation occurs during the initiation phase of apoptosis. We titrated down the amount of FADD transfected into HeLa and 293T cells until it was insufficient for apoptosis, although cycloheximide (CHX) still triggered the effector phase. Even in the absence of CHX, ceramide levels increased rapidly, peaking at 2.7 +/- 0.2-fold of control 8 h post-transfection. Dominant negative FADD failed to confer ceramide generation or CHX-mediated apoptosis. Ceramide generation induced by FADD was initiator caspase-dependent, being blocked by crmA. Limited pro-caspase 8 overexpression also increased ceramide levels 2.7 +/- 0.2-fold, yet failed, without CHX, to initiate apoptosis. Expression of membrane-targeted oligomerized CD-8 caspase 8 induced apoptosis without CHX, yet elevated ceramide only to a level equivalent to limited pro-caspase 8 transfection. Ceramide elevations were detected concurrently by diacylglycerol kinase and electrospray tandem mass spectrometry. These investigations provide evidence that ceramide generation is initiator caspase-dependent and occurs prior to commitment to the effector phase of apoptosis, definitively ordering ceramide as proximal in CD95 signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722705     DOI: 10.1074/jbc.275.12.8650

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosis.

Authors:  C Rodriguez-Lafrasse; G Alphonse; P Broquet; M T Aloy; P Louisot; R Rousson
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells.

Authors:  Makoto Sumitomo; Motoi Ohba; Junichi Asakuma; Takako Asano; Toshio Kuroki; Tomohiko Asano; Masamichi Hayakawa
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes.

Authors:  Bärbel Edelmann; Uwe Bertsch; Vladimir Tchikov; Supandi Winoto-Morbach; Cristiana Perrotta; Marten Jakob; Sabine Adam-Klages; Dieter Kabelitz; Stefan Schütze
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

4.  Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice.

Authors:  Carmen García-Ruiz; Anna Colell; Montserrat Marí; Albert Morales; María Calvo; Carlos Enrich; José C Fernández-Checa
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 5.  Glycosphingolipids and mitochondria: role in apoptosis and disease.

Authors:  Albert Morales; Anna Colell; Montserrat Mari; Carmen Garcia-Ruiz; José C Fernandez-Checa
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Ceramide inhibits PKCθ by regulating its phosphorylation and translocation to lipid rafts in Jurkat cells.

Authors:  Rouba Hage-Sleiman; Asmaa B Hamze; Aimée F El-Hed; Randa Attieh; Lina Kozhaya; Sarah Kabbani; Ghassan Dbaibo
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

7.  Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis.

Authors:  Montserrat Marí; Anna Colell; Albert Morales; Covadonga Pañeda; Isabel Varela-Nieto; Carmen García-Ruiz; José C Fernández-Checa
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  Apoptotic sphingolipid ceramide in cancer therapy.

Authors:  Wei-Ching Huang; Chia-Ling Chen; Yee-Shin Lin; Chiou-Feng Lin
Journal:  J Lipids       Date:  2011-01-13

9.  Apoptosis and sphingomyelin hydrolysis. The flip side.

Authors:  D R Green
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

10.  Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin.

Authors:  Jan Simák; Karel Holada; Jaroslav G Vostal
Journal:  BMC Cell Biol       Date:  2002-05-28       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.